机译:决定结果传播和遗传测试被已知的BRCA1 / 2突变的家庭的因素。
Esme FinlayDivision of Hematology/Oncology, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.Jill E. StopferAbramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.Eric BurlingameAbramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.Katherine Goldfeder EvansAbramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.Katherine L. NathansonAbramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.Division of Medical Genetics, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.Barbara L. WeberGlaxoSmithKline, Philadelphia, Pennsylvania.Katrina ArmstrongAbramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania.Timothy R. RebbeckAbramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania.Susan M. DomchekDivision of Hematology/Oncology, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.;
Factors Determining Dissemination;
机译:决定结果传播和遗传测试被已知的BRCA1 / 2突变的家庭的因素。
机译:患有BRCA1 / 2 BRCA1 / 2或MMR基因突变的家族内部影响及对遗传检测产生遗传检测的证据的心理社会及临床因素
机译:已知BRCA1突变的挪威家庭对遗传性测试和心理困扰的预测水平的掌握
机译:BRCA1基因突变类型在乳腺癌及其亲属患者中BRCA1基因突变类型的分子遗传学研究
机译:BRCA1和BRCA2突变载体对BRCA突变的直接消费遗传检测的视角
机译:决定结果传播和遗传测试被已知的BRCA1 / 2突变的家庭的因素。
机译:利用已知BRCA1突变的挪威家族的遗传检测和精神痛苦预测水平
机译:代谢酶中的危险因素和遗传多态性对BRCa1和BRCa2突变携带者和非突变携带者乳腺癌风险的影响